List of works - Adrian Paul Mander

A Review of Perspectives on the Use of Randomization in Phase II Oncology Trials

scientific article published on 01 December 2019

A phase 2 study of vatalanib in metastatic melanoma patients

scientific article published on 25 August 2010

A product of independent beta probabilities dose escalation design for dual-agent phase I trials.

scientific article

A proposed method of bias adjustment for meta-analyses of published observational studies.

scientific article

A prospective analysis of dietary energy density at age 5 and 7 years and fatness at 9 years among UK children

scientific article published on 02 October 2007

Acute effects of hyperglycaemia on asymmetric dimethylarginine (ADMA), adiponectin and inflammatory markers (IL-6, hs-CRP) in overweight and obese women with metabolic syndrome.

scientific article published on January 2010

Adaptive designs for dual-agent phase I dose-escalation studies

scientific article published on 19 March 2013

Admissible multiarm stepped-wedge cluster randomized trial designs

scientific article published on 6 November 2018

Admissible two-stage designs for phase II cancer clinical trials that incorporate the expected sample size under the alternative hypothesis.

scientific article

An adaptive design for updating the threshold value of a continuous biomarker.

scientific article published on 14 July 2016

Bayesian hierarchical methods to interpret the (13)C-octanoic acid breath test for gastric emptying ⬇️

scientific article published on January 1, 2011

Designing and evaluating dose-escalation studies made easy: The MoDEsT web app

scientific article published on 19 December 2019

Diet and glycosylated haemoglobin in the 1946 British birth cohort.

scientific article published on 24 June 2009

Dietary energy density and adiposity: employing bias adjustments in a meta-analysis of prospective studies

scientific article

Escalation strategies for combination therapy Phase I trials ⬇️

scientific article published on March 12, 2012

Extended and standard duration weight-loss programme referrals for adults in primary care (WRAP): a randomised controlled trial

scientific article

Genetic predisposition to type 2 diabetes is associated with impaired insulin secretion but does not modify insulin resistance or secretion in response to an intervention to lower dietary saturated fat.

scientific article

How much human milk do infants consume? Data from 12 countries using a standardized stable isotope methodology.

scientific article

Incorporation of eicosapentaenoic and docosahexaenoic acids into lipid pools when given as supplements providing doses equivalent to typical intakes of oily fish.

scientific article

Is sugar-sweetened beverage consumption associated with increased fatness in children?

scientific article published on 01 July 2007

Minimizing the Maximum Expected Sample Size in Two-Stage Phase II Clinical Trials with Continuous Outcomes ⬇️

scientific article published on January 1, 2012

Modelling semi-attributable toxicity in dual-agent phase I trials with non-concurrent drug administration

scientific article published on 19 February 2016

Moderate ingestion of alcohol is associated with acute ethanol-induced suppression of circulating CTX in a PTH-independent fashion.

scientific article published on August 2009

Multiple sclerosis recurrence risk for siblings in an isolated population of Central Sardinia, Italy

article

Objectively measured physical activity and fat mass in children: a bias-adjusted meta-analysis of prospective studies

scientific article

Primary care referral to a commercial provider for weight loss treatment versus standard care: a randomised controlled trial

scientific article published on 7 September 2011

Reducing sample sizes in two-stage phase II cancer trials by using continuous tumour shrinkage end-points.

scientific article published on 14 January 2011

Sample size re-estimation in crossover trials: application to the AIM HY-INFORM study

scientific article published on 02 December 2019

Toxicity-dependent feasibility bounds for the escalation with overdose control approach in phase I cancer trials

scientific article

Two-stage designs optimal under the alternative hypothesis for phase II cancer clinical trials.

scientific article published on August 2010

Variation in the urokinase-plasminogen activator gene does not explain the chromosome 10 linkage signal for late onset AD.

scientific article published in January 2004

Weight loss referrals for adults in primary care (WRAP): protocol for a multi-centre randomised controlled trial comparing the clinical and cost-effectiveness of primary care referral to a commercial weight loss provider for 12 weeks, referral [...]

scientific article

List of works by Adrian Paul Mander

A Review of Perspectives on the Use of Randomization in Phase II Oncology Trials

A phase 2 study of vatalanib in metastatic melanoma patients

A product of independent beta probabilities dose escalation design for dual-agent phase I trials.

A proposed method of bias adjustment for meta-analyses of published observational studies.

A prospective analysis of dietary energy density at age 5 and 7 years and fatness at 9 years among UK children

Acute effects of hyperglycaemia on asymmetric dimethylarginine (ADMA), adiponectin and inflammatory markers (IL-6, hs-CRP) in overweight and obese women with metabolic syndrome.

Adaptive designs for dual-agent phase I dose-escalation studies

Admissible multiarm stepped-wedge cluster randomized trial designs

Admissible two-stage designs for phase II cancer clinical trials that incorporate the expected sample size under the alternative hypothesis.

An adaptive design for updating the threshold value of a continuous biomarker.

Bayesian hierarchical methods to interpret the (13)C-octanoic acid breath test for gastric emptying ⬇️

Designing and evaluating dose-escalation studies made easy: The MoDEsT web app

Diet and glycosylated haemoglobin in the 1946 British birth cohort.

Dietary energy density and adiposity: employing bias adjustments in a meta-analysis of prospective studies

Escalation strategies for combination therapy Phase I trials ⬇️

Extended and standard duration weight-loss programme referrals for adults in primary care (WRAP): a randomised controlled trial

Genetic predisposition to type 2 diabetes is associated with impaired insulin secretion but does not modify insulin resistance or secretion in response to an intervention to lower dietary saturated fat.

How much human milk do infants consume? Data from 12 countries using a standardized stable isotope methodology.

Incorporation of eicosapentaenoic and docosahexaenoic acids into lipid pools when given as supplements providing doses equivalent to typical intakes of oily fish.

Is sugar-sweetened beverage consumption associated with increased fatness in children?

Minimizing the Maximum Expected Sample Size in Two-Stage Phase II Clinical Trials with Continuous Outcomes ⬇️

Modelling semi-attributable toxicity in dual-agent phase I trials with non-concurrent drug administration

Moderate ingestion of alcohol is associated with acute ethanol-induced suppression of circulating CTX in a PTH-independent fashion.

Multiple sclerosis recurrence risk for siblings in an isolated population of Central Sardinia, Italy

Objectively measured physical activity and fat mass in children: a bias-adjusted meta-analysis of prospective studies

Primary care referral to a commercial provider for weight loss treatment versus standard care: a randomised controlled trial

Reducing sample sizes in two-stage phase II cancer trials by using continuous tumour shrinkage end-points.

Sample size re-estimation in crossover trials: application to the AIM HY-INFORM study

Toxicity-dependent feasibility bounds for the escalation with overdose control approach in phase I cancer trials

Two-stage designs optimal under the alternative hypothesis for phase II cancer clinical trials.

Variation in the urokinase-plasminogen activator gene does not explain the chromosome 10 linkage signal for late onset AD.

Weight loss referrals for adults in primary care (WRAP): protocol for a multi-centre randomised controlled trial comparing the clinical and cost-effectiveness of primary care referral to a commercial weight loss provider for 12 weeks, referral [...]